Novo Nordisk CEO Lars Jorgensen testifies in U.S. Senate hearing on high cost of weight loss drugs, in Washington
- Código: 27854785
- Data do Conteúdo: 24/09/2024
- Inclusão no Site: 24/09/2024 11:33:53
- Assunto: USA-CONGRESS/NOVO
- Legenda: Novo Nordisk CEO Lars Jorgensen testifies before a Senate Health, Education, Labor, and Pensions Committee hearing on U.S. prices for the weight loss drugs Ozempic and Wegovy, on Capitol Hill in Washington, U.S., September 24, 2024. REUTERS/Piroschka van de Wouw ORG XMIT: LIVE
- Serviço/Categoria: Reuters / Reuters Internacional
- Crédito: Reuters/Folhapress
- Dimensão: 40cm x 27cm
- Tamanho: 14.86 megapixels
- Resolução: 300 dpi
- Palavras-chave: N/A